Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 120 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1191 10.0 months Malignant Mesothelioma 4 Chemotherapy
National University Hospital, Rigshospitalet Denmark 4/1999
Treatment Details: Patients: This Phase II study involved 26 patients with malignant mesothelioma. (24 patients had pleural mesothelioma.) Treatment: The treatment consisted of administration of the chemoth
 
1192 10.0 months Metastatic or relapsed NSCLC 5 Chemotherapy
Centre Hospitalier Lyon-Sud France 12/2002
Treatment Details: Patients: This Phase III trial involved a total of 259 patients with metastatic or relapsed non-small cell lung cancer. Patients were divided into two groups: Group A comprised of 133 patie
 
1193 10.0 months Malignant Pleural Mesothelioma 5 Biologic therapy
Surgery
The Netherlands Cancer Institute Netherlands 10/2001
Treatment Details: Patients: This Phase I/II study involved 28 patients with malignant pleural mesothelioma. Treatment: The treatment consisted of surgery (pleuropneumonectomy) with intraoperative photody
 
1194 10.0 months Metastatic breast cancer 4 Chemotherapy
University Hospital of Helsinki Finland 5/2003
Treatment Details: Patients: This Phase II trial involved a total of 60 patients with metastatic breast cancer. Patients were divided into three groups (Groups 1-3). Group 1 had 26 patients, group 2 had 24
 
1195 10.0 months GBM 4 Biologic therapy
Radiation
Dana-Farber/Brigham and Women’s Cancer Center United States 10/2012
Treatment Details: Patients: This phase 2 study involved 89 newly diagnosed glioblastoma patients. The median patient age was not given but 62% were male. Treatment: Patients were treated with radiation
 
1196 10.0 months Malignant pleural mesothelioma 5 Biologic therapy
University of Arizona Cancer Center United States 6/2007
Treatment Details: Patients: This phase 2 study involved 64 malignant pleural mesothelioma patients who had not received prior chemotherapy. The median patient age was 69.5 years and 75% were male. Treatm
 
1197 10.0 months Non-Hodgkin lymphoma 4 Chemotherapy
Advocate Lutheran General Hospital United States 4/2011
Treatment Details: Patients: This phase 2 study involved 26 previously treated non-Hodgkin lymphoma patients. The median patient age was 69 years and 45% were male. Treatment: Patients were treated with
 
1198 10.0 months Advanced NSCLC 5 Chemotherapy
Immunotherapy
Royal Victoria Hospital Canada 7/2011
Treatment Details: Patients: This phase II study involved advanced non-small-cell lung cancer patients who had not received prior chemotherapy. Patients were divided into two separate treatment groups. Grou
 
1199 10.0 months NHL 5 Chemotherapy
Hormone
Azienda Ospedale Universita` Padova Italy 8/2005
Treatment Details: Patients: This phase II study involved 30 non-Hodgkin’s lymphoma patients who were in frail condition. The median patient age was 83 years and 33% were male. Treatment: Patients were t
 
1200 10.0 months Malignant mesothelioma 4 Biologic therapy
UCSF Helen Diller Family Comprehensive Cancer Center United States 12/2011
Treatment Details: Patients: This phase II study involved 47 untreated malignant mesothelioma patients with a median age of 75 years; 91% were male. Treatment: Patients were treated with the biologic ther
 
Page 120 of 187  | Previous Page  | Next Page